14:40:08 EDT Thu 16 May 2024
Enter Symbol
or Name
USA
CA



Think Research Corp
Symbol THNK
Shares Issued 78,108,233
Close 2023-08-23 C$ 0.28
Market Cap C$ 21,870,305
Recent Sedar Documents

Think Research to release Q2 results Aug. 29

2023-08-23 17:05 ET - News Release

Mr. Mark Sakamoto reports

THINK RESEARCH ANNOUNCES DATE OF SECOND QUARTER AND YEAR-TO-DATE 2023 RESULTS AND CONFERENCE CALL DETAILS

Think Research Corp. will release second quarter and year-to-date results prior to the market open on Tuesday, Aug. 29, 2023. Think's financial statements and management's discussion and analysis will be available under the company's profile on SEDAR and on the company's website as of 7:15 a.m. Eastern Time. Prior to market open on Tuesday, Aug. 29, 2023, at 9 a.m. EST, chief executive officer Sachin Aggarwal and chief financial officer John Hayes will host a conference call to discuss the results, with a question-and-answer (Q&A) session to follow.

Time and date:  9 a.m. EST, Tuesday, Aug. 29, 2023

Conference call participant details

To join the conference call without operator assistance, you may register and enter your phone number on-line to receive an instant automated callback. Participants can also dial direct to be entered to the call by an operator.

Toronto:  416-764-8659

North American toll-free:  1-888-664-6392

Conference replay

Local:  416-764-8677

North American toll-free:  1-888-390-0541

Replay entry code:  197171 followed by the pound key

Expiration date:  Sept. 3, 2023

About Think Research Corp.

Think Research is an industry leader in delivering knowledge-based digital health software solutions. The company's focused mission is to organize the world's health knowledge so everyone gets the best care. Its evidence-based health care technology solutions support the clinical decision-making process and standardize care, to facilitate better health care outcomes. The company gathers, develops and delivers knowledge-based solutions globally to customers, which typically include enterprise clients, hospitals, health regions, health care professionals and/or governments. The company has gathered a significant amount of data by building its repository of knowledge through its network and group of companies, including acquired companies.

Think Research licenses its solutions to over 1,600 facilities for over 326,000 primary care, acute care and long-term care doctors, nurses and pharmacists who rely on the content and data provided by Think Research to support their practices. Over three million patients and residents annually receive better care due to the essential data that Think Research produces, manages and delivers.

In addition, the company collects and manages pharmaceutical and clinical trial data via the BioPharma Services entity that Think Research acquired on Sept. 10, 2021. BioPharma Services is a leading provider of bioequivalence and phase 1 clinical research services to pharmaceutical companies globally. Think Research's other services include a network of digital-first primary care clinics and medical clinics that provide elective surgery.

© 2024 Canjex Publishing Ltd. All rights reserved.